中国人寿(02628) - 2024 Q1 - 季度业绩

Financial Performance - Net profit attributable to shareholders decreased by 9.3% to RMB 20,644 million from RMB 22,770 million in the same period last year[2] - Operating revenue increased by 14.4% to RMB 120,970 million compared to RMB 105,713 million in the same period last year[2] - Basic and diluted earnings per share decreased by 9.3% to RMB 0.73 from RMB 0.81 in the same period last year[2] - The weighted average return on equity decreased by 1.70 percentage points to 4.31% from 6.01% in the previous year[2] - The total profit for the group was RMB 26,771 million, compared to RMB 25,653 million in Q1 2023, indicating a year-over-year increase of 4.4%[17] - The group's operating profit was RMB 26,868 million, an increase from RMB 25,740 million in the previous year, marking a growth of 4.4%[17] - The total comprehensive income attributable to shareholders of the parent company was RMB 3,286 million, down from RMB 26,155 million in Q1 2023[19] Assets and Liabilities - Total assets reached RMB 6,070,843 million, an increase of 7.4% compared to the end of the previous year[2] - The total liabilities of the group as of March 31, 2024, were RMB 5,580,095 million, compared to RMB 5,316,011 million as of December 31, 2023, reflecting an increase of 4.9%[15] - The insurance contract liabilities reached RMB 5,241,249 million, up from RMB 4,859,175 million, indicating an increase of 7.9%[15] - The company's total assets as of January 1, 2024, are RMB 5,511,324 million, an increase of RMB 154,325 million compared to December 31, 2023[29] - Total liabilities as of January 1, 2024, amount to RMB 5,316,011 million, a slight decrease of RMB 959 million from December 31, 2023[28] Cash Flow - The net cash flow from operating activities was RMB 183,759 million, reflecting a 4.4% increase from RMB 175,980 million in the previous year[2] - In Q1 2024, the company generated net cash flow from operating activities of RMB 183,759 million, an increase from RMB 175,980 million in Q1 2023, representing a growth of approximately 4.5%[21] - Total cash inflow from investment activities was RMB 572,600 million in Q1 2024, compared to RMB 406,307 million in Q1 2023, marking an increase of about 40.9%[23] - The net cash flow from financing activities in Q1 2024 was negative RMB 77,644 million, a decline from negative RMB 65,283 million in Q1 2023, indicating a worsening of approximately 18.2%[25] - The total cash and cash equivalents at the end of Q1 2024 reached RMB 254,217 million, compared to RMB 172,842 million at the end of Q1 2023, showing an increase of approximately 47.0%[25] Insurance Performance - In Q1 2024, total insurance premiums reached RMB 337.64 billion, a year-on-year increase of 3.2% from RMB 327.22 billion in Q1 2023[12] - New single premiums amounted to RMB 112.44 billion, down 4.4% from RMB 117.67 billion in the same period last year[12] - First-year regular premiums were RMB 74.83 billion, an increase of 4.7% compared to RMB 71.48 billion in Q1 2023[12] - The proportion of first-year regular premiums for ten years and above reached 33.67%, up 5.57 percentage points from the previous year[10] - Insurance service revenue was RMB 53,773 million, up from RMB 47,183 million, reflecting a growth of 14.4% year-over-year[16] Investment Performance - Total investment income for Q1 2024 was RMB 64.66 billion, a year-on-year increase of 7.2%[11] - Net investment income was RMB 42.68 billion, showing a slight decline of 0.1% year-on-year[11] - Investment income decreased to RMB 5,464 million from RMB 54,338 million, reflecting a substantial decline[16] - The company's long-term equity investments increased to RMB 266,428 million from RMB 258,872 million, a growth of 2.4%[14] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 131,444, with the largest shareholder holding 68.37%[6] - Shareholders' equity attributable to the parent company increased by 46.6% to RMB 480,406 million from RMB 327,784 million at the end of the previous year[2] - The company's equity attributable to shareholders increased to RMB 480,406 million from RMB 327,784 million, showing a substantial growth of 46.5%[15] Accounting Standards - The company implemented new accounting standards for insurance contracts and financial instruments starting January 1, 2024, affecting the presentation of comparative period information[1] - The company will implement new accounting standards for insurance contracts and financial instruments starting January 1, 2024, with a transition date of January 1, 2022, affecting the comparative data[13] - The company has disclosed the new balance sheet as of January 1, 2024, reflecting the impact of the new accounting standards[13]